The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.

New, flexible (7, 9, 11 and 13) and rigid (8, 10, 12 and 14) imides with a 1-(m-trifluorophenyl)piperazine fragment and a tetramethylene or a 1e,4e-cyclohexylene spacer, respectively, showed very high affinity (K(i)=0.3-34 nM) and agonistic in vivo activity for 5-HT(1A) receptors. Flexible new compounds and the previously described 5 also bound to 5-HT(7) receptors (K(i)=21-134 nM). Selected glutarimide derivatives, that is, the most potent postsynaptic 5-HT(1A) receptor agonist rigid compound 8 and its flexible analogue 7, as well as the previously described full agonist-rigid compound 6 and the partial agonist-its flexible counterpart 5 exhibited moderate affinity for alpha(1)-adrenoceptors (K(i)=85 - 268 nM), but were practically devoid of any affinity for dopamine D(2) sites. Those glutarimides demonstrated anxiolytic- (5 and 7) and antidepressant-like (5, 6 and 8) activity in the four-plate and the swim tests in mice, respectively; at the same time, however, they inhibited the locomotor activity of mice. The antidepressant-like effect of 8 was significantly stronger than that induced by imipramine used as a reference antidepressant.

[1]  S. Handley.  5-Hydroxytryptamine pathways in anxiety and its treatment. , 1995, Pharmacology & therapeutics.

[2]  E. Przegaliński,et al.  The role of postsynaptic 5-HT1A receptors in the anticonflict effect of ipsapirone , 1994, Neuropharmacology.

[3]  N. Andén,et al.  Selective blockade of brainα 2-autoreceptors by yohimbine: Effects on motor activity and on turnover of noradrenaline and dopamine , 2005, Journal of Neural Transmission.

[4]  G. Goodwin,et al.  The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(DI-n-propylamino)tetralin (8-OH-DPAT) A model of presynaptic 5-HT1 function , 1985, Neuropharmacology.

[5]  P. Simon,et al.  Evaluation of a rapid technique for detecting minor tranquilizers. , 1971, Neuropharmacology.

[6]  H. Berendsen,et al.  Selective activation of 5HT1A receptors induces lower lip retraction in the rat , 1989, Pharmacology Biochemistry and Behavior.

[7]  J. Hagan,et al.  Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719 , 1998, British journal of pharmacology.

[8]  G. Perrault,et al.  Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT1A receptor antagonists , 1999, Psychopharmacology.

[9]  J. Vry.  5-HT1A receptor agonists: recent developments and controversial issues , 1995, Psychopharmacology.

[10]  A. Bojarski,et al.  On the bioactive conformation of NAN-190 (1) and MP3022 (2), 5-HT(1A) receptor antagonists. , 1999, Journal of medicinal chemistry.

[11]  M. Filip,et al.  Structure-activity relationship studies of central nervous system agents. 13. 4-[3-(Benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)piperazine, a new putative 5-HT1A receptor antagonist, and its analogs. , 1994, Journal of medicinal chemistry.

[12]  M. Nowak,et al.  Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry. , 2006, Journal of medicinal chemistry.

[13]  L. Strekowski,,et al.  Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel α1, 5-HT1A and 5-HT2A receptor ligands , 1996 .

[14]  A. Bojarski,et al.  Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity. , 2006, Bioorganic & medicinal chemistry.

[15]  E. Przegaliński,et al.  Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats , 1991, Neuropharmacology.

[16]  M. López-Rodríguez,et al.  Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A af , 1999, Journal of medicinal chemistry.

[17]  E. Tatarczyńska,et al.  Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression , 2004, Behavioural pharmacology.

[18]  C. López-Rubalcava.  Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm , 1996, Pharmacology Biochemistry and Behavior.

[19]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[20]  A. Wesołowska,et al.  Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists. , 2003, European journal of pharmacology.

[21]  G. Perrault,et al.  The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety , 2000, Neuropharmacology.

[22]  A. Bojarski,et al.  1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. , 2005, Bioorganic & medicinal chemistry.

[23]  I A Cliffe,et al.  A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.

[24]  A. Bojarski,et al.  Active conformation of some arylpiperazine postsynaptic 5-HT(1A) receptor antagonists. , 2002, European journal of medicinal chemistry.

[25]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[26]  A. Wesołowska,et al.  Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. , 2006, European journal of pharmacology.

[27]  H. Berendsen,et al.  Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats. , 1991, Behavioral and neural biology.